These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8959858)

  • 1. Effect of RS61443 in combination with leflunomide or FK506 on rat heart allograft survival.
    Antoniou E; DeRoover A; Nishimura Y; Howie AJ; McMaster P; D'Silva M
    Transpl Int; 1996; 9 Suppl 1():S331-3. PubMed ID: 8959858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive effect of combination schedules of brequinar with leflunomide or tacrolimus on rat cardiac allotransplantation.
    Antoniou EA; Deroover A; Howie AJ; Chondros K; McMaster P; D'Silva M
    Microsurgery; 1999; 19(2):98-102. PubMed ID: 10188834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunomodulatory effects of a novel agent, leflunomide, in rat cardiac allotransplantation.
    D'Silva M; Candinas D; Achilleos O; Lee SJ; Dalgic A; Miki C; Mayer AD; McMaster P
    Transpl Int; 1994; 7 Suppl 1():S378-80. PubMed ID: 11271257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive effect of RS-61443 on rat cardiac allograft survival in combination with leflunomide or FK 506.
    D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P
    Transplant Proc; 1996 Apr; 28(2):930-1. PubMed ID: 8623467
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhancement of allograft survival by combination RS-61443 and DUP-785 therapy.
    Kawamura T; Hullett DA; Suzuki Y; Bechstein WO; Allison AM; Sollinger HW
    Transplantation; 1993 Apr; 55(4):691-4; discussion 694-5. PubMed ID: 8475537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FK506 treatment in combination with leflunomide in hamster-to-rat heart and liver xenograft transplantation.
    Sankary HN; Yin DP; Chong AS; Ma LL; Blinder L; Shen JK; Foster P; Williams JW
    Transplantation; 1998 Oct; 66(7):832-7. PubMed ID: 9798690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined immunosuppressive therapy with low dose FK506 and antimetabolites in rat allogeneic heart transplantation.
    Tanabe M; Todo S; Murase N; Irish W; Miyazawa H; Fujisaki S; Starzl TE
    Transplantation; 1994 Jul; 58(1):23-7. PubMed ID: 7518619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limb xenotransplantation using FK506 and RS61443 immunosuppression.
    Hebebrand D; Jones NF; Zohman G; Rao U; Soleiman N
    J Reconstr Microsurg; 1998 Apr; 14(3):191-4. PubMed ID: 9590615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival of an extremity composite tissue allograft with FK506-mycophenolate mofetil therapy.
    Jones JW; Ustüner ET; Zdichavsky M; Edelstein J; Ren X; Maldonado C; Ray M; Jevans AW; Breidenbach WC; Gruber SA; Barker JH
    Surgery; 1999 Aug; 126(2):384-8. PubMed ID: 10455910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant IL-33 prolongs leflunomide-mediated graft survival by reducing IFN-γ and expanding CD4(+)Foxp3(+) T cells in concordant heart transplantation.
    Dai C; Lu FN; Jin N; Yang B; Gao C; Zhao B; Fu JZ; Hong SF; Liang HT; Chen LH; Chen ZS; Chen J; Qi ZQ
    Lab Invest; 2016 Aug; 96(8):820-9. PubMed ID: 27295346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506.
    D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P
    Transplant Proc; 1996 Apr; 28(2):950-1. PubMed ID: 8623476
    [No Abstract]   [Full Text] [Related]  

  • 12. The superior effect of the combination of FK 506 and deoxyspergualin on rat cardiac allograft survival.
    Jiang H; Takahara S; Li D; Namiki M; Ishibashi M; Okuyama A; Sonoda T
    Transpl Int; 1994 Aug; 7(5):315-8. PubMed ID: 7527637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WOFIE augments the immunosuppressive potency of FK-506. Window of opportunity for immunological engagement.
    Dresske B; Zavazava N; Huang DS; Lin X; Kremer B; Fändrich F
    Transpl Immunol; 1998 Dec; 6(4):243-9. PubMed ID: 10342738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of long-term immunosuppression for limb transplantation using cyclosporine, tacrolimus, and mycophenolate mofetil: implications for clinical composite tissue transplantation.
    Jones NF; Hebebrand D; Buttemeyer R; Zhao M; Benhaim P; Rao U
    Plast Reconstr Surg; 2001 Mar; 107(3):777-84. PubMed ID: 11304605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A short-term combination therapy with cyclosporine and rapamycin or leflunomide induces long-term heart allograft survival in a strongly immunogenic strain combination in rats.
    Lin Y; Vandeputte M; Waer M
    Transpl Int; 1996; 9 Suppl 1():S328-30. PubMed ID: 8959857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of FK 506, mycophenolate mofetil, and aminoguanidine effects on delay of corneal allograft rejection in an experimental model of low-risk and high-risk keratoplasty.
    Svozílková P; Bysterská P; Masek K; Valenta Z; Zvárová J; Farghali H
    Immunopharmacol Immunotoxicol; 2006; 28(2):335-40. PubMed ID: 16873100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental study of the effectiveness of immunosuppression therapy using FK506 and 15-deoxyspergualin in concordant xenotransplantation].
    Maeda T
    Nihon Kyobu Geka Gakkai Zasshi; 1997 Jun; 45(6):841-5. PubMed ID: 9217381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus and mycophenolate mofetil provide effective immunosuppression in rat laryngeal transplantation.
    Nelson M; Fritz M; Dan O; Worley S; Strome M
    Laryngoscope; 2003 Aug; 113(8):1308-13. PubMed ID: 12897551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor pretreatment with leflunomide has an adverse effect on rat cardiac allograft survival.
    DeRoover A; Williams A; Hubscher S; Candinas D; Antoniou E; Howie A; Drayson M; McMaster P; D'Silva M
    Transpl Immunol; 1997 Jun; 5(2):136-41. PubMed ID: 9269036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.